| http://www.w3.org/ns/prov#value | - The dog trial results have been built in the share price around $6.70 which is the price of the merger.The iplex farce here has now been proven for what it always has been since the company dropped the drug in 2009, for 11 million in rights.,not billions from the clown car.NTM is an orphan drug with a small population.Extrapolating out because of possible or potential additional markets is an ex
|
